Company Filing History:
Years Active: 2025
Title: Michał Kowaiski: Innovator in Therapeutic Applications
Introduction
Michał Kowaiski is a notable inventor based in Godziszka, Poland. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic applications related to chitinase-like proteins.
Latest Patents
Kowaiski holds a patent for YKL-40 inhibitors. This patent discloses assays for screening active compounds that interfere with the interaction between chitinase-like protein YKL-40 and chitin oligomers, as well as with heparan sulfate. The patent also identifies active compounds that serve as inhibitors of YKL-40, detailing their therapeutic applications and their use in biosensors for measuring YKL-40 levels in biological samples. He has 1 patent to his name.
Career Highlights
Michał Kowaiski is associated with Molecure S.A., a company focused on innovative drug development. His work has been instrumental in advancing therapeutic strategies that target specific proteins involved in various diseases.
Collaborations
Kowaiski collaborates with notable colleagues, including Łukasz Krzemiński and Wojciech J Czestkowski. Their combined expertise enhances the research and development efforts at Molecure S.A.
Conclusion
Michał Kowaiski's contributions to the field of biotechnology, particularly through his patent on YKL-40 inhibitors, highlight his role as an innovator in therapeutic applications. His work continues to pave the way for advancements in medical science.